Baxter International

Selected news for the capital firm - Baxter International, collected since 10/2017. Recent stories appear in zolmax.com and The Markets Daily. This capital firm shares healthcare news with Medtronic, Pfizer, COVID-19, Abbott Laboratories, Boston Scientific and over a hundred others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/19/2021 Gamco Investors INC. ET AL Sells 806 Shares of Baxter International Inc. (NYSE:BAX) baseballnewssource.com Gamco Investors INC. ET AL Sells 806 Shares of Baxter International Inc. (NYSE:BAX) Posted by Grant Hamersma on Feb 19th, 2021 TweetGamco Investors INC. ET AL reduced its stake in Baxter International Inc. (NYSE:BAX) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,204 shares of the medical instruments supplier’s ...
2/19/2021 Global Hemostatic Agents Market 2020 report by top Companies: Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, etc. mathematicexperts.com Emerging News Global Hemostatic Agents Market 2020 report by top Companies: Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, etc. Global Hemostatic Agents Market 2020 report by top Companies: Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, etc. Sushree Sasmita Hemostatic Agents , Hemostatic Agents Industry , Hemostatic Agents MarketGlobal Hemostatic Agents Research Report 2020 includes all basic information related to the global Industry and forecast until ...
2/19/2021 Baxter International Inc. (NYSE:BAX) Shares Acquired by New York State Common Retirement Fund dispatchtribunal.com US Crude Prices Plummet 4% as Russia and OPEC Consider Easing CapsNew York State Common Retirement Fund raised its stake in shares of Baxter International Inc. (NYSE:BAX) by 19.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,505,563 shares of the medical instruments supplier’s stock after buying an additional 401,586 shares during the period. New York State Common Retirement Fund’s holdings in Baxter ...
2/18/2021 Baxter International Inc. (NYSE:BAX) Shares Purchased by SG Americas Securities LLC baseballnewssource.com Baxter International Inc. (NYSE:BAX) Shares Purchased by SG Americas Securities LLC Posted by James ConleySG Americas Securities LLC boosted its position in Baxter International Inc. (NYSE:BAX) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,188 shares of the medical instruments supplier’s stock after acquiring an additional 1,075 shares during the quarter. SG Americas ...
2/18/2021 Analysts Offer Insights on Healthcare Companies: Avanos Medical (AVNS) and Integra Lifesciences (IART) markets.co ... 46.37.According to TipRanks.com , Keusch is a 4-star analyst with an average return of 9.9% and a 72.1% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International , and Intuitive Surgical.Avanos Medical has an analyst consensus of Hold, with a price target consensus of $50.00.Integra Lifesciences (IART)In a report released today, Jayson Bedford from Raymond James maintained a Hold ...
2/18/2021 Baxter International Inc. (BAX) To Go Ex- on February 25th wkrb13.com ... 1.26%. of this dividend is Thursday, February 25th.Baxter International has raised its dividend by 56.6% over the last three years and has raised its dividend annually for the last 5 consecutive years.Get Baxter International alerts: Shares of NYSE:BAX opened at $77.68 on Thursday. The firm has a market cap of $39.24 billion, a P/E ratio of 44.14, a P/E/G ratio of 2.53 and a ...
2/18/2021 Whitener Capital Management Purchases 500 Shares of Baxter International Inc. (NYSE:BAX) Ticker Report Whitener Capital Management Inc. boosted its position in Baxter International Inc. (NYSE:BAX) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,292 shares of the medical instruments supplier’s stock after acquiring an additional 500 shares during the period. Whitener Capital Management Inc.’s holdings in Baxter International were worth $1,387,000 at the end of ...
2/18/2021 Fibrosarcoma -Industry Overview, Demands Competitive Players Johnson & Johnson, Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Novartis AG, Sun Pharmaceutical Industries Limited express-press-release.net Fibrosarcoma -Industry Overview, Demands Competitive Players Johnson & Johnson, Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Novartis AG, Sun Pharmaceutical Industries Limited, Posted on 2021-02-18 by XploreMR in Healthcare // 0 CommentsCITY, Country, 2021-Feb-18 — /EPR Network/ —Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no ...
2/18/2021 Gabelli Funds LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) Ticker Report Gabelli Funds LLC cut its holdings in shares of Baxter International Inc. (NYSE:BAX) by 0.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 213,425 shares of the medical instruments supplier’s stock after selling 525 shares during the quarter. Gabelli Funds LLC’s holdings in Baxter International were worth $17,125,000 at the end of ...
2/18/2021 Global Regenerative Medicine Market for Bone and Joint to Surpass US$ 14,074.3 Million by 2027, Says Coherent Market Insights (CMI) financialbuzz.com ... Analysis:Major players in the global regenerative medicine (bone and joint) market are focused on approvals and launches of new products to expand their product portfolio in the market. For instance, in July 2020, Baxter International Inc, announced that they received the U.S. Food Drug Administration clearance for its Altapore Shape bioactive bone graft for bone growth and fusion. Altapore Shape is used as a standalone bone graft substitute or ...
2/18/2021 Becton Dickinson (BDX) Receives a Buy from Raymond James markets.co ... 256.82.According to TipRanks.com , Keusch is a 4-star analyst with an average return of 9.9% and a 72.1% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International , and Intuitive Surgical.The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Becton Dickinson with a $286.50 average price target, implying an 11.6% upside from current levels. In ...
2/18/2021 Patient-Controlled Analgesia Pumps Market Research Report Including SWOT Analysis, PESTEL Analysis, Drivers, Restraints, Global Industry Outlook and Key Players Analysis By 2027 heraldkeeper.com ... covering market shares and profiles key participants in the global Patient-Controlled Analgesia Pumps market share. Major industry players with significant revenue share include Smiths Group, PLC, Ace Medical Co. Ltd., Micrel Medical Devices, Baxter International etc.Browse Full Report: https://www.marketresearchengine.com/patient-controlled-analgesia-pumps-marketPatient controlled analgesia pump is the method used to control the amount of analgesia that patients receive. A PCA pump is a computerized ...
2/16/2021 Analysts Offer Insights on Healthcare Companies: Hill-Rom (NYSE: HRC), Ocular Therapeutix (NASDAQ: OCUL) and Antares Pharma (NASDAQ: ATRS) analystratings.com ... 107.72.According to TipRanks.com , Keusch is a 4-star analyst with an average return of 10.6% and a 75.8% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International , and Intuitive Surgical.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Hill-Rom with a $121.67 average price target, which is a 12.5% upside from current levels ...
2/16/2021 Cancer Immunomodulator Market Research Report by Type, by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 heraldkeeper.com ... Forecast 2017-2024.”The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Cancer Immunomodulator market share. Major industry players with significant revenue share include AbGenomics Corporation, Baxter International , Amgen, ANI Pharmaceuticals, Biovest International, company, and others.The global Cancer Immunomodulator market is segregated on the basis of Product as Method of Use: CoQ9 and Method of Use: Levamisole Coating Agent. Based on ...
2/16/2021 Burn Care Products & Accessories Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026 heraldkeeper.com ... scope includes detailed competitive outlook covering market shares and profiles key participants in the global Burn Care Products & Accessories market share. Major industry players with significant revenue share include Smith and Nephew, 3M Company, Baxter International , Convatec, Derma Science, Medtronic, Molnlycke healthcare, Coloplast, Johnson & Johnson (Ethicon), Hollister, and others.The global burn care product & accessories market is predicted to witness a positive growth throughout the forecast amount. Rising incidence of ...
2/16/2021 Baxter International Inc. (NYSE:BAX) Shares Sold by JNB Advisors LLC rivertonroll.com Baxter International Inc. (NYSE:BAX) Shares Sold by JNB Advisors LLC Posted by Lars Charter on Feb 16th, 2021 TweetJNB Advisors LLC reduced its stake in Baxter International Inc. (NYSE:BAX) by 17.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,120 shares of the medical instruments supplier’s stock after selling 4,320 shares during the ...
2/16/2021 Baxter International Inc. (NYSE:BAX) to Issue Quarterly Dividend of $0.25 dispatchtribunal.com ... annualized dividend and a dividend yield of 1.26%.Baxter International has raised its dividend by 56.6% over the last three years and has raised its dividend every year for the last 5 years. Get Baxter International alerts:Shares of NYSE:BAX traded down $0.77 during mid-day trading on Tuesday, hitting $77.96. 8,779 shares of the company traded hands, compared to its average volume of 2,815,938. The stock has a ...
2/16/2021 Baxter International Inc. ( NYSE:BAX ), a leading wapakdailynews.com ... Äôs rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter , LinkedIn and Facebook .Baxter is a registered trademark of Baxter International Inc. //www.businesswire.com/news/home/20210216006154/en/Contacts:Media ContactStacey Eisen, (224) [email protected] Stocks: Baxter International ...
2/15/2021 Intensifying Insights across Drug Delivery Devices Global Market Outlook: Ken Research kenresearch.com ... analysis of,’ Drug Delivery Devices Global Market Report 2020-30: Covid 19 Implications and Growth ’ Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International , BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc. Companies in the drug delivery devices market are collaborating with other firms within the industry so as to support their ...
2/15/2021 Intensifying Insights across Drug Delivery Devices Global Market Outlook: Ken Research kenresearch.com ... analysis of,’ Drug Delivery Devices Global Market Report 2020-30: Covid 19 Implications and Growth ’ Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International , BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc. Companies in the drug delivery devices market are collaborating with other firms within the industry so as to support their ...